CGTN anchor Zheng Junfeng interviewed AstraZeneca CEO Pascal Soriot, delving into the company's extensive strategic layout in China's pharmaceutical industry. From focusing on the domestic market to becoming a core base for global manufacturing and innovation, AstraZeneca has strengthened its business in China through significant investments in Wuxi and Qingdao, as well as a strong emphasis on research and development, contributing to the advancement of global health and economic growth.